Vsevolozhsk, Russia

Andrei Ivanovich Alafinov

This inventor holds 1 USPTO granted patent and 1 published patent application. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrei Ivanovich Alafinov. Retrieved from https://idiyas.com/inventor/andrei-ivanovich-alafinov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andrei Ivanovich Alafinov

Introduction: Andrei Ivanovich Alafinov is a notable inventor based in G. Vsevolozhsk, Russia. He has made significant contributions to the field of pharmaceuticals, particularly through his work on CDK8/19 inhibitors. His innovative approach has led to the development of novel compounds that hold promise for treating various diseases and disorders.

Latest Patents: Alafinov holds a patent for CDK8/19 inhibitors, which are compounds designed to inhibit the activity of cyclin-dependent kinases 8 and 19. This invention is crucial as it relates to a pharmaceutical composition that can be used as a medicine, showcasing his commitment to advancing medical science.

Career Highlights: Throughout his career, Alafinov has focused on the intersection of chemistry and medicine. His research has led to breakthroughs that enhance the understanding of disease mechanisms and potential treatments. His dedication to innovation is evident in his patent, which reflects his expertise and vision in the pharmaceutical field.

Collaborations: Alafinov has worked alongside talented colleagues, including Aleksei Leonidovich Mindich and Anna Jur'evna Chestnova. Their collaborative efforts have contributed to the success of his research and the development of impactful medical solutions.

Conclusion: Andrei Ivanovich Alafinov's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of CDK8/19 inhibitors, highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…